Study of Elenestinib (BLU-263) in Advanced Systemic Mastocytosis (AdvSM) and and Other KIT Altered Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Advanced Systemic Mastocytosis
Related studies linked through entity extraction aliases.
Retrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSM
- Status
- COMPLETED
- Phase
- N/A
(PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis
- Status
- COMPLETED
- Phase
- PHASE2
A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1